<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medvis</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская визуализация</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Visualization</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0763</issn><issn pub-type="epub">2408-9516</issn><publisher><publisher-name>RDS-Media Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24835/1607-0763-1341</article-id><article-id custom-type="elpub" pub-id-type="custom">medvis-1341</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАЛЫЙ ТАЗ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SMALL PELVIS</subject></subj-group></article-categories><title-group><article-title>Лучевая диагностика рака шейки матки. Консенсус экспертов</article-title><trans-title-group xml:lang="en"><trans-title>Imaging of cervical cancer. Consensus of experts</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8378-4338</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рубцова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rubtsova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рубцова Наталья Алефтиновна – доктор мед. наук, заведующая отделом лучевой диагностики</p><p>125284 Москва, 2-й Боткинский проезд, 3</p></bio><bio xml:lang="en"><p>Natalia A. Rubtsova – Doct. of Sci. (Med.), Head of the department of radiation diagnostics</p><p>3, 2nd Botkinsky proezd, Moscow 125284</p></bio><email xlink:type="simple">rna17@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3549-4499</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Березовская</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Berezovskaia</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Березовская Татьяна Павловна – доктор мед. наук, профессор, заведующая отделением магнитно-резонансной томографии</p><p>249031 Калужская область, г. Обнинск, ул. Маршала Жукова, д. 10</p></bio><bio xml:lang="en"><p>Tatiana P. Berezovskaia – Doct. of Sci. (Med.), Professor, Head of the MRI department </p><p>10, Zhukov str., Obninsk 249031, Kaluga region</p></bio><email xlink:type="simple">berez@mrrc.obninsk.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1459-4124</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Быченко</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Bychenko</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Быченко Владимир Геннадьевич – канд. мед. наук, заведующий отделением лучевой диагностики</p><p>117997 Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>Vladimir G. Bychenko – Cand. of Sci. (Med.), Head of radiation diagnostics department</p><p>4, Akademika Oparina str., Moscow 117997</p></bio><email xlink:type="simple">vbychenko@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5652-1580</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павловская</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlovskaya</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Павловская Евгения Александровна – канд. мед. наук, врач-рентгенолог</p><p>197758 Санкт Петербург, пос. Песочный, ул. Ленинградская, д. 68</p></bio><bio xml:lang="en"><p>Evgenya A. Pavlovskaya – Cand. of Sci. (Med.), Radiologist</p><p>68, Leningradskaya str., Pesochny, Saint- Petersburg 197758</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4768-115X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Солопова</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Solopova</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Солопова Алина Евгеньевна – доктор мед. наук, старший научный сотрудник отделения лучевой диагностики</p><p>117997 Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>Alina E. Solopova – Doct. of Sci. (Med.), Senior Researcher of the radiation diagnostics department </p><p>4, Akademika Oparina str., Moscow 117997</p></bio><email xlink:type="simple">a_solopova@oparina4.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0406-0046</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агабабян</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Agababyan</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Агабабян Татев Артаковна – канд. мед. наук, заведующий отделением лучевой диагностики</p><p>249031 Калужская область, г. Обнинск, ул. Маршала Жукова, д. 10</p></bio><bio xml:lang="en"><p>Tatev A. Agababyan – Cand. of Sci. (Med.), Head of radiation diagnostics department </p><p>10, Zhukov str., Obninsk 249031, Kaluga region</p></bio><email xlink:type="simple">agababyan@mrrc.obninsk.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2172-5778</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ходжибекова</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Khodzhibekova</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ходжибекова Малика Маратовна – доктор мед. наук, врач-радиолог отделения радионуклидной диагностики</p><p>125284 Москва, 2-й Боткинский проезд, 3</p></bio><bio xml:lang="en"><p>Malika M. Khodzhibekova – Doct. of Sci. (Med.), Radiologist of the Radionuclide Diagnostics Department </p><p>3, 2nd Botkinsky proezd, Moscow 125284</p></bio><email xlink:type="simple">malika_25@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рыжкова</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryzhkova</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рыжкова Дарья Викторовна – доктор мед. наук, профессор РАН, главный научный сотрудник научно-исследовательского отдела ядерной медицины и тераностики Института онкологии и гематологии, руководитель научно-клинического объединения ядерной медицины, заведующая кафедрой ядерной медицины и радиационных технологий с клиникой Института медицинского образования Центра Алмазова</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Daria V. Ryzhkova – Doct. of Sci. (Med.), Professor, Chief Researcher of research department of nuclear medicine and theranostics of the institute of oncology and hematology, Head of the scientific and clinical association of nuclear medicine, head of the department of nuclear medicine and radiation technologies with the clinic of the institute of medical education of the Almazov Center</p><p>2, Akkuratova str., Saint-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5661-2589</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чекалова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chekalova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чекалова Марина Альбертовна – доктор мед. наук, профессор, врач ультразвуковой диагностики АПО ФНКЦ ФМБА России; профессор ФГАОУ ВО “Российский университет дружбы народов им. Патриса Лумумбы” Минобрнауки России</p><p>125310 Москва, Волоколамское шоссе, 30</p></bio><bio xml:lang="en"><p>Marina A. Chekalova – Doct. of Sci. (Med.), Professor, doctor of ultrasonic diagnostics of Federal Scientific and Clinical Center for Special Types of Medical Care and Medical Technologies The Federal Medical Biological Agency (FMBA of Russia); Professor, The Peoples' Friendship University of Russia</p><p>30, Volokolamskoye shosse, Moscow 125310</p></bio><email xlink:type="simple">ch2me@yandex.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5799-1269</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мешкова</surname><given-names>И. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Meshkova</surname><given-names>I. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мешкова Ирина Евгеньевна – канд. мед. наук, врач ультразвуковой диагностики, онкогинеколог </p><p>197758 Санкт Петербург, пос. Песочный, ул. Ленинградская, д. 68</p></bio><bio xml:lang="en"><p>Irina E. Meshkova – Cand. of Sci. (Med.), ultrasound diagnostic doctor, gynecological oncologist</p><p>68, Leningradskaya str., Pesochny, Saint- Petersburg 197758</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4742-9157</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гажонова</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Gazhonova</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гажонова Вероника Евгеньевна – доктор мед. наук, профессор, заведующая кабинетом ультразвуковой ангиографии, врач ультразвуковой диагностики</p><p>121359 Москва, ул. Маршала Тимошенко д.19, с.1А</p></bio><bio xml:lang="en"><p>Veronica E. Gazhonova – Doct. of Sci. (Med.), Professor, Head of the ultrasound angiography room, ultrasound diagnostics doctor </p><p>19, bld. 1А, Marshal Timoshenko str., Moscow 121359</p></bio><email xlink:type="simple">vx969@yandex.ru</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1377-3128</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гус</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Gus</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гус Александр Иосифович – доктор мед. наук, профессор, главный научный сотрудник отделения ультразвуковой и функциональной диагностики отдела визуальной диагностики</p><p>117997 Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>Alexandr I. Gus – Doct. of Sci. (Med.), Professor, Chief Researcher of department of ultrasound and functional diagnostics, visual diagnostics department </p><p>4, Akademika Oparina str., Moscow 117997</p></bio><email xlink:type="simple">A_gus@oparina4.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4131-6293</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Багненко</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bagnenko</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Багненко Сергей Сергеевич – доктор мед. наук, доцент, заведующий научным отделением, ведущий научный сотрудник научного отделения диагностической и интервенционной радиологии</p><p>197758 Санкт Петербург, пос. Песочный, ул. Ленинградская, д. 68</p></bio><bio xml:lang="en"><p>Sergey S. Bagnenko – Doct. of Sci. (Med.), associate Professor, Head of the scientific department, Leading Researcher of the scientific department of diagnostic and interventional radiology</p><p>68, Leningradskaya str., Pesochny, Saint- Petersburg 197758</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1779-003X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Медведева</surname><given-names>Б. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Medvedeva</surname><given-names>B. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Медведева Бэла Михайловна – доктор мед. наук, профессор, заведующая отделением рентгенодиагностики, ведущий научный сотрудник</p><p>115478 Москва, Каширское шоссе, д. 23</p></bio><bio xml:lang="en"><p>Bela M. Medvedeva – Doct. of Sci. (Med.), Professor, Head of the department of X-ray diagnostics, Leading Researcher</p><p>23, Kashirskoe shosse, Moscow 115478</p></bio><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6396-4948</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ашрафян</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ashrafyan</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ашрафян Левон Андреевич – академик РАН, доктор мед. наук, профессор, заместитель директора</p><p>117997 Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>Levon A. Ashrafyan – Academician of the Russian Academy of Sciences, Doct. of Sci. (Med.), Professor, Deputy Director</p><p>4, Akademika Oparina str., Moscow 117997</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2768-5698</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новикова Елена Григорьевна – доктор мед. наук, профессор, заместитель начальника отдела опухолей репродуктивных и мочевыводящих органов</p><p>125284 Москва, 2-й Боткинский проезд, 3</p></bio><bio xml:lang="en"><p>Elena G. Novikova – Doct. of Sci. (Med.), Professor, Deputy Head of the Department of Tumors of the Reproductive and Urinary Organs</p><p>3, 2nd Botkinsky proezd, Moscow 125284</p></bio><email xlink:type="simple">mnioi@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6937-2740</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Берлев</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Berlev</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Берлев Игорь Викторович – доктор мед. наук, профессор, заведующий отделением онкогинекологии</p><p>197758 Санкт Петербург, пос. Песочный, ул. Ленинградская, д. 68</p></bio><bio xml:lang="en"><p>Igor V. Berlev – Doct. of Sci. (Med.), Professor, Head of the department of oncogynecology</p><p>68, Leningradskaya str., Pesochny, Saint- Petersburg 197758</p></bio><email xlink:type="simple">iberlev@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2104-0859</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демидова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Demidova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Демидова Людмила Владимировна – доктор мед. наук, ведущий научный сотрудник отдела лучевой терапии</p><p>125284 Москва, 2-й Боткинский проезд, 3</p></bio><bio xml:lang="en"><p>Ludmila V. Demidova – Doct. of Sci. (Med.), Leading Researcher of the department of radiation therapy </p><p>3, 2nd Botkinsky proezd, Moscow 125284</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1842-156X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крикунова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Krikunova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Крикунова Людмила Ивановна – доктор мед. наук, профессор, главный научный сотрудник отделения лучевых и комбинированных методов лечения гинекологических заболеваний с группой восстановительной и эстетической медицины</p><p>249031 Калужская область, г. Обнинск, ул. Маршала Жукова, д. 10</p></bio><bio xml:lang="en"><p>Lyudmola I. Krikunova – Doct. of Sci. (Med.), Professor, Сhief scientific officer of the Department of Radiation and Combined Methods of Treatment of Gynecological Diseases with the Group of Restorative and Aesthetic Medicine</p><p>10, Zhukov str., Obninsk 249031, Kaluga region</p></bio><email xlink:type="simple">krikunova_li@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6854-8940</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коломиец</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolomiets</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коломиец Лариса Александровна – доктор мед. наук, профессор, заведующая отделением гинекологии</p><p>634009 Томск, Кооперативный пер., 5</p></bio><bio xml:lang="en"><p>Larisa A. Kolomiets – Doct. of Sci. (Med.), Professor, Head of the department of gynecology</p><p>5, Kooperativny per., Tomsk 634009</p></bio><xref ref-type="aff" rid="aff-9"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>P. Hertsen Moscow oncology research institute – Branch of National Medical Research Radiological Centre of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>МРНЦ им. А.Ф. Цыба – филиал ФГБУ “НМИЦ радиологии” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation (A. Tsyb MRRC)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ “Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Center for Obstetrics, Gynecology and Perinatology named by V.I. Kulakov of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ “ Национальный медицинский исследовательский центр онкологии им. Н.Н. Петрова” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Petrov National Medical Research Center of Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГБУ “Национальный медицинский исследовательский центр им. В.А. Алмазова”</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Академия постдипломного образования ФНКЦ Федерального медико-биологического агентства (ФМБА России)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific and Clinical Center for Special Types of Medical Care and Medical Technologies the Federal Medical Biological Agency (FMBA of Russia)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>ФГБУ ДПО “Центральная государственная медицинская академия” Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy Administration of the President of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>НИИ клинической и экспериментальной радиологии ФГБУ “Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Clinical and Experimental Radiology, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-9"><aff xml:lang="ru"><institution>НИИ онкологии Томского национального исследовательского медицинского центра РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Oncology, Tomsk National medical research Center of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2023</year></pub-date><volume>28</volume><issue>1</issue><fpage>141</fpage><lpage>156</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рубцова Н.А., Березовская Т.П., Быченко В.Г., Павловская Е.А., Солопова А.Е., Агабабян Т.А., Ходжибекова М.М., Рыжкова Д.В., Чекалова М.А., Мешкова И.Е., Гажонова В.Е., Гус А.И., Багненко С.С., Медведева Б.М., Ашрафян Л.А., Новикова Е.Г., Берлев И.В., Демидова Л.В., Крикунова Л.И., Коломиец Л.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Рубцова Н.А., Березовская Т.П., Быченко В.Г., Павловская Е.А., Солопова А.Е., Агабабян Т.А., Ходжибекова М.М., Рыжкова Д.В., Чекалова М.А., Мешкова И.Е., Гажонова В.Е., Гус А.И., Багненко С.С., Медведева Б.М., Ашрафян Л.А., Новикова Е.Г., Берлев И.В., Демидова Л.В., Крикунова Л.И., Коломиец Л.А.</copyright-holder><copyright-holder xml:lang="en">Rubtsova N.A., Berezovskaia T.P., Bychenko V.G., Pavlovskaya E.A., Solopova A.E., Agababyan T.A., Khodzhibekova M.M., Ryzhkova D.V., Chekalova M.A., Meshkova I.E., Gazhonova V.E., Gus A.I., Bagnenko S.S., Medvedeva B.M., Ashrafyan L.A., Novikova E.G., Berlev I.V., Demidova L.V., Krikunova L.I., Kolomiets L.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medvis.rdsmedia.ru/jour/article/view/1341">https://medvis.rdsmedia.ru/jour/article/view/1341</self-uri><abstract><p>Представленная статья отражает современный взгляд на возможности диагностического алгоритма рака шейки матки (РШМ) – одного из наиболее часто встречаемых злокачественных новообразований женской репродуктивной системы. Алгоритм изложен в виде консенсуса ведущих специалистов по лучевой диагностике и онкогинекологов, занимающихся проблемами диагностики и лечения РШМ. В статье изложены основные тренды по использованию методов лучевой диагностики, их роли и возможностях для стадирования РШМ, планированию и оценке эффективности проводимой терапии, динамическому наблюдению за пациентками, прошедшими специализированное противоопухолевое лечение.</p></abstract><trans-abstract xml:lang="en"><p>The article offers the latest view on possibilities of diagnostic algorithm to identify cervical cancer (CC), one of the most incidental tumor of the woman’s reproductive system. The algorithm is described as a consensus of leading expert in imaging diagnostics, as well as oncogynecologysts, investigating diagnostic challenges and cervical cancer therapies. The article sets forth the principal trends in using imaging methods, their role and possibilities for staging CC, planning and assessing the efficacy of applied therapy, on-going surveillance over patients, who have undergone specialized anti-cancer treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>МРТ</kwd><kwd>УЗИ</kwd><kwd>ПЭТ/КТ</kwd><kwd>18 F-фтордезоксиглюкоза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>imaging</kwd><kwd>MRI</kwd><kwd>US</kwd><kwd>FGD PET/CT</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet. 2009; 105 (2): 103–104. http://doi.org/10.1016/j.ijgo.2009.02.012</mixed-citation><mixed-citation xml:lang="en">FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet. 2009; 105 (2): 103–104. http://doi.org/10.1016/j.ijgo.2009.02.012</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the cervix uteri. Int. J. Gynaecol. Obstet. 2019; 145 (1): 129–135. http://doi.org/10.1002/ijgo.12749</mixed-citation><mixed-citation xml:lang="en">FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the cervix uteri. Int. J. Gynaecol. Obstet. 2019; 145 (1): 129–135. http://doi.org/10.1002/ijgo.12749</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 2018; 143 (Suppl. 2): 22–36. http://doi.org/10.1002/ijgo.12611</mixed-citation><mixed-citation xml:lang="en">Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 2018; 143 (Suppl. 2): 22–36. http://doi.org/10.1002/ijgo.12611</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Berek J.S., Matsuo K., Grubbs B.H. et al. Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. J. Gynecol. Oncol. 2019; 30 (2): e40. http://doi.org/10.3802/jgo.2019.30.e40</mixed-citation><mixed-citation xml:lang="en">Berek J.S., Matsuo K., Grubbs B.H. et al. Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. J. Gynecol. Oncol. 2019; 30 (2): e40. http://doi.org/10.3802/jgo.2019.30.e40</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri”. Int. J. Gynecol. Obstet. 2019; 145: 129–135. http://doi.org/10.1002/ijgo.12969</mixed-citation><mixed-citation xml:lang="en">Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri”. Int. J. Gynecol. Obstet. 2019; 145: 129–135. http://doi.org/10.1002/ijgo.12969</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.I., Atri M. 2018 FIGO staging system for uterine cervical cancer: enter cross-sectional imaging. Radiology. 2019; 292 (1): 15–24. http://doi.org/10.1148/radiol.2019190088</mixed-citation><mixed-citation xml:lang="en">Lee S.I., Atri M. 2018 FIGO staging system for uterine cervical cancer: enter cross-sectional imaging. Radiology. 2019; 292 (1): 15–24. http://doi.org/10.1148/radiol.2019190088</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Olawaiye A.B., Baker T.P., Washington M.K., Mutch D.G. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J. Clin. 2021; 71 (4): 287–298. http://doi.org/10.3322/caac.21663</mixed-citation><mixed-citation xml:lang="en">Olawaiye A.B., Baker T.P., Washington M.K., Mutch D.G. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J. Clin. 2021; 71 (4): 287–298. http://doi.org/10.3322/caac.21663</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">FIGO CANCER REPORT 2021 Cancer of the cervix uteri: 2021 update International Journal of Obstetrics and Gynaecology. 155 (S1). Special Issue: FIGO Cancer Report 2021 October: 28–44. https://doi.org/10.1002/ijgo.13967</mixed-citation><mixed-citation xml:lang="en">FIGO CANCER REPORT 2021 Cancer of the cervix uteri: 2021 update International Journal of Obstetrics and Gynaecology. 155 (S1). Special Issue: FIGO Cancer Report 2021 October: 28–44. https://doi.org/10.1002/ijgo.13967</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации, одобренные научным советом МЗ РФ, Рак шейки матки, 2020 г. 48 с. https://oncology.ru/specialist/treatment/references/actual/537.pdf?ysclid=lp6m9w7k57670993368</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines approved by the scientific council of the Ministry of Health of the Russian Federation, Cervical Cancer, 2020, 48 p. (In Russian) https://oncology.ru/specialist/treatment/references/actual/537.pdf?ysclid=lp6m9w7k57670993368</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tian Y., Luo H. Diagnostic accuracy of transvaginal ultrasound examination for local staging of cervical cancer: a systematic review and meta-analysis. Med. Ultrason. 2022; 24 (3): 348–355. http://doi.org/10.11152/mu-3246</mixed-citation><mixed-citation xml:lang="en">Tian Y., Luo H. Diagnostic accuracy of transvaginal ultrasound examination for local staging of cervical cancer: a systematic review and meta-analysis. Med. Ultrason. 2022; 24 (3): 348–355. http://doi.org/10.11152/mu-3246</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cibula D., Pötter R., Planchamp F. et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int. J. Gynecol. Cancer. 2018; 28 (4): 641–655. http://doi.org/10.1097/IGC.0000000000001216</mixed-citation><mixed-citation xml:lang="en">Cibula D., Pötter R., Planchamp F. et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int. J. Gynecol. Cancer. 2018; 28 (4): 641–655. http://doi.org/10.1097/IGC.0000000000001216</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Marth C., Landoni F., Mahner S. et al.; ESMO Guidelines Committee. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; 28 (Suppl_4): iv72–iv83. http://doi.org/10.1093/annonc/mdx220</mixed-citation><mixed-citation xml:lang="en">Marth C., Landoni F., Mahner S. et al.; ESMO Guidelines Committee. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; 28 (Suppl_4): iv72–iv83. http://doi.org/10.1093/annonc/mdx220</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chino J., Annunziata C.M., Beriwal S. et al. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract. Radiat. Oncol. 2020; 10 (4): 220–234. http://doi.org/10.1016/j.prro.2020.04.002</mixed-citation><mixed-citation xml:lang="en">Chino J., Annunziata C.M., Beriwal S. et al. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract. Radiat. Oncol. 2020; 10 (4): 220–234. http://doi.org/10.1016/j.prro.2020.04.002</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hricak H., Gatsonis C., Chi D.S. et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J. Clin. Oncol. 2005; 23 (36): 9329–9337. http://doi.org/10.1200/JCO.2005.02.0354</mixed-citation><mixed-citation xml:lang="en">Hricak H., Gatsonis C., Chi D.S. et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J. Clin. Oncol. 2005; 23 (36): 9329–9337. http://doi.org/10.1200/JCO.2005.02.0354</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao M., Yan B., Li Y. et al. Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis. Eur. Radiol. 2020; 30 (3): 1405–1418. http://doi.org/10.1007/s00330-019-06461-9</mixed-citation><mixed-citation xml:lang="en">Xiao M., Yan B., Li Y. et al. Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis. Eur. Radiol. 2020; 30 (3): 1405–1418. http://doi.org/10.1007/s00330-019-06461-9</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Thomeer M.G., Gerestein C., Spronk S. et al. Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma:systematic review and meta-analysis. Eur. Radiol. 2013; 23: 2005–2018. http://doi.org/10.1007/s00330-013-2783-4</mixed-citation><mixed-citation xml:lang="en">Thomeer M.G., Gerestein C., Spronk S. et al. Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma:systematic review and meta-analysis. Eur. Radiol. 2013; 23: 2005–2018. http://doi.org/10.1007/s00330-013-2783-4</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Manganaro L., Lakhman Y., Bharwani N. et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur. Radiol. 2021; 31 (10): 7802–7816. http://doi.org/10.1007/s00330-020-07632-9. Erratum in: Eur. Radiol. 2021 Jun 17. PMID: 33852049</mixed-citation><mixed-citation xml:lang="en">Manganaro L., Lakhman Y., Bharwani N. et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur. Radiol. 2021; 31 (10): 7802–7816. http://doi.org/10.1007/s00330-020-07632-9. Erratum in: Eur. Radiol. 2021 Jun 17. PMID: 33852049</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bourgioti C., Chatoupis K., Moulopoulos L.A. Current imaging strategies for the evaluation of uterine cervical cancer. Wld J. Radiol. 2016; 8 (4): 342–354. http://doi.org/10.4329/wjr.v8.i4.342</mixed-citation><mixed-citation xml:lang="en">Bourgioti C., Chatoupis K., Moulopoulos L.A. Current imaging strategies for the evaluation of uterine cervical cancer. Wld J. Radiol. 2016; 8 (4): 342–354. http://doi.org/10.4329/wjr.v8.i4.342</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nogami Y., Iida M., Banno K. et al. Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects. Anticancer Res. 2014; 34 (2): 585–592. PMID: 24510987</mixed-citation><mixed-citation xml:lang="en">Nogami Y., Iida M., Banno K. et al. Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects. Anticancer Res. 2014; 34 (2): 585–592. PMID: 24510987</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mirpour S., Mhlanga J., Logeswaran P. et al. The role of PET/CT in the management of cervical cancer. Am. J. Roentgenol. 2013; 201 (2): W192–205. http://doi.org/10.2214/AJR.12.9830</mixed-citation><mixed-citation xml:lang="en">Mirpour S., Mhlanga J., Logeswaran P. et al. The role of PET/CT in the management of cervical cancer. Am. J. Roentgenol. 2013; 201 (2): W192–205. http://doi.org/10.2214/AJR.12.9830</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Choi H.J., Ju W., Myung S.K., Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci. 2010; 101 (6): 1471–1479. http://doi.org/10.1111/j.1349-7006.2010.01532.x</mixed-citation><mixed-citation xml:lang="en">Choi H.J., Ju W., Myung S.K., Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci. 2010; 101 (6): 1471–1479. http://doi.org/10.1111/j.1349-7006.2010.01532.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Liu B., Gao S., Li S. A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/ CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a metaanalysis based on 67 studies. Gynecol. Obstet Invest. 2017; 82 (3): 209–222. http://doi.org/10.1159/000456006</mixed-citation><mixed-citation xml:lang="en">Liu B., Gao S., Li S. A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/ CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a metaanalysis based on 67 studies. Gynecol. Obstet Invest. 2017; 82 (3): 209–222. http://doi.org/10.1159/000456006</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ruan J., Zhang Y., Ren H. Meta-analysis of PET/CT Detect Lymph Nodes Metastases of Cervical Cancer. Open Med. (Wars.) 2018; 13: 436–442. http://doi.org/10.1515/med-2018-0065</mixed-citation><mixed-citation xml:lang="en">Ruan J., Zhang Y., Ren H. Meta-analysis of PET/CT Detect Lymph Nodes Metastases of Cervical Cancer. Open Med. (Wars.) 2018; 13: 436–442. http://doi.org/10.1515/med-2018-0065</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Young P., Daniel B., Sommer G. et al. Intravaginal gel for staging of female pelvic cancers–preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J. Comput. Assist. Tomogr. 2012; 36 (2): 253–256. http://doi.org/10.1097/RCT.0b013e3182483c05</mixed-citation><mixed-citation xml:lang="en">Young P., Daniel B., Sommer G. et al. Intravaginal gel for staging of female pelvic cancers–preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J. Comput. Assist. Tomogr. 2012; 36 (2): 253–256. http://doi.org/10.1097/RCT.0b013e3182483c05</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Van Hoe L., Vanbeckevoort D., Oyen R. et al. Cervical carcinoma: optimized local staging with intravaginal contrast-enhanced MR imaging–preliminary results. Radiology. 1999; 213 (2): 608–611. http://doi.org/10.1148/radiology.213.2.r99oc23608</mixed-citation><mixed-citation xml:lang="en">Van Hoe L., Vanbeckevoort D., Oyen R. et al. Cervical carcinoma: optimized local staging with intravaginal contrast-enhanced MR imaging–preliminary results. Radiology. 1999; 213 (2): 608–611. http://doi.org/10.1148/radiology.213.2.r99oc23608</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Akata D., Kerimoglu U., Hazirolan T. et al. Efficacy of transvaginal contrast-enhanced MRI in the early staging of cervical carcinoma. Eur. Radiol. 2005; 15 (8): 1727–1733. https://doi.org/10.1007/s00330-005-2645-9</mixed-citation><mixed-citation xml:lang="en">Akata D., Kerimoglu U., Hazirolan T. et al. Efficacy of transvaginal contrast-enhanced MRI in the early staging of cervical carcinoma. Eur. Radiol. 2005; 15 (8): 1727–1733. https://doi.org/10.1007/s00330-005-2645-9</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Wang L., Li Y., Song P. The value of diffusionweighted imaging in combination with conventional magnetic resonance imaging for improving tumor detection for early cervical carcinoma treated with fertility-sparing surgery. Int. J. Gynecol. Cancer. 2017; 27 (8):1761–1768. http://doi.org/10.1097/IGC.0000000000001113</mixed-citation><mixed-citation xml:lang="en">Li X., Wang L., Li Y., Song P. The value of diffusionweighted imaging in combination with conventional magnetic resonance imaging for improving tumor detection for early cervical carcinoma treated with fertility-sparing surgery. Int. J. Gynecol. Cancer. 2017; 27 (8):1761–1768. http://doi.org/10.1097/IGC.0000000000001113</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Woo S., Moon M.H., Cho J.Y. et al. Diagnostic performance of MRI for assessing parametrial invasion in cervical cancer: a head-to-head comparison between oblique and true axial T2-weighted images. Korean J. Radiol. 2019; 20 (3): 378–384. http://doi.org/10.3348/kjr.2018.0248</mixed-citation><mixed-citation xml:lang="en">Woo S., Moon M.H., Cho J.Y. et al. Diagnostic performance of MRI for assessing parametrial invasion in cervical cancer: a head-to-head comparison between oblique and true axial T2-weighted images. Korean J. Radiol. 2019; 20 (3): 378–384. http://doi.org/10.3348/kjr.2018.0248</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hori M., Kim T., Onishi H. et al Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T-initial experience. Radiology. 2011; 258 (1): 154–163. http://doi.org/10.1148/radiol.10100866</mixed-citation><mixed-citation xml:lang="en">Hori M., Kim T., Onishi H. et al Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T-initial experience. Radiology. 2011; 258 (1): 154–163. http://doi.org/10.1148/radiol.10100866</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang J., Hong S.S., Kim H.J. et al. Reduced field-of-view diffusion-weighted MRI in patients with cervical cancer. Br. J. Radiol. 2018; 91 (1087): 20170864. http://doi.org/10.1259/bjr.20170864</mixed-citation><mixed-citation xml:lang="en">Hwang J., Hong S.S., Kim H.J. et al. Reduced field-of-view diffusion-weighted MRI in patients with cervical cancer. Br. J. Radiol. 2018; 91 (1087): 20170864. http://doi.org/10.1259/bjr.20170864</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Huang J.-W., Song J.-C., Chen T. et al. Making the invisible visible: improving detectability of MRI-invisible residual cervical cancer after conisation by DCE-MRI. Clin. Radiol. 2019; 74 (2): 166.e15–166.e21. http://doi.org/10.1016/j.crad.2018.10.013</mixed-citation><mixed-citation xml:lang="en">Huang J.-W., Song J.-C., Chen T. et al. Making the invisible visible: improving detectability of MRI-invisible residual cervical cancer after conisation by DCE-MRI. Clin. Radiol. 2019; 74 (2): 166.e15–166.e21. http://doi.org/10.1016/j.crad.2018.10.013</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bermudez A., Bhatla N., Leung E. FIGO cancer report 2015. Cancer of the cervix uteri. Int. J. Gynecol. Obstet. 2015; 131: S88–95. http://doi.org/10.1016/j.ijgo.2015.06.004</mixed-citation><mixed-citation xml:lang="en">Bermudez A., Bhatla N., Leung E. FIGO cancer report 2015. Cancer of the cervix uteri. Int. J. Gynecol. Obstet. 2015; 131: S88–95. http://doi.org/10.1016/j.ijgo.2015.06.004</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Bentivegna E., Gouy S., Maulard A. et al. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol. 2016; 17 (6): e240–e253. http://doi.org/10.1016/S1470-2045(16)30032-8</mixed-citation><mixed-citation xml:lang="en">Bentivegna E., Gouy S., Maulard A. et al. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol. 2016; 17 (6): e240–e253. http://doi.org/10.1016/S1470-2045(16)30032-8</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Q., Li W., Kanis M.J. et al. Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. Oncotarget. 2017; 8 (28): 46580–46592. http://doi.org/10.18632/oncotarget.16233</mixed-citation><mixed-citation xml:lang="en">Zhang Q., Li W., Kanis M.J. et al. Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. Oncotarget. 2017; 8 (28): 46580–46592. http://doi.org/10.18632/oncotarget.16233</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Bentivegna E., Maulard A., Pautier P. et al. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the Literature. Fertil Steril. 2016; 106 (5): 1195–1211.e5. https://doi.org/10.1016/j.fertnstert.2016.06.032</mixed-citation><mixed-citation xml:lang="en">Bentivegna E., Maulard A., Pautier P. et al. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the Literature. Fertil Steril. 2016; 106 (5): 1195–1211.e5. https://doi.org/10.1016/j.fertnstert.2016.06.032</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Koh W.J., Abu-Rustum N.R., Bean S. et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2019; 17 (1): 64–84. http://doi.org/10.6004/jnccn.2019.0001</mixed-citation><mixed-citation xml:lang="en">Koh W.J., Abu-Rustum N.R., Bean S. et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2019; 17 (1): 64–84. http://doi.org/10.6004/jnccn.2019.0001</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Engin G. Cervical cancer: MR imaging findings before, during, and after radiation therapy. Eur. Radiol. 2006; 16 (2): 313–324. http://doi.org/10.1007/s00330-005-2804-z</mixed-citation><mixed-citation xml:lang="en">Engin G. Cervical cancer: MR imaging findings before, during, and after radiation therapy. Eur. Radiol. 2006; 16 (2): 313–324. http://doi.org/10.1007/s00330-005-2804-z</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Hricak H., Yu K.K. Radiology in invasive cervical cancer. Am. J. Roentgenol. 1996; 167: 1101–1108. http://doi.org/10.2214/ajr.167.5.8911159</mixed-citation><mixed-citation xml:lang="en">Hricak H., Yu K.K. Radiology in invasive cervical cancer. Am. J. Roentgenol. 1996; 167: 1101–1108. http://doi.org/10.2214/ajr.167.5.8911159</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Lakhman Y., Akin O., Park K.J. et al. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology. 2013; 269 (1): 149–158. https://doi.org/10.1148/radiol.13121746</mixed-citation><mixed-citation xml:lang="en">Lakhman Y., Akin O., Park K.J. et al. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology. 2013; 269 (1): 149–158. https://doi.org/10.1148/radiol.13121746</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Noël P., Dubé M., Plante M., St-Laurent G. Early cervical carcinoma and fertility-sparing treatment options: MR imaging as a tool in patient selection and a follow-upmodality. Radiographics. 2014; 34 (4): 1099–1119. https://doi.org/10.1148/rg.344130009</mixed-citation><mixed-citation xml:lang="en">Noël P., Dubé M., Plante M., St-Laurent G. Early cervical carcinoma and fertility-sparing treatment options: MR imaging as a tool in patient selection and a follow-upmodality. Radiographics. 2014; 34 (4): 1099–1119. https://doi.org/10.1148/rg.344130009</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Downey K., Attygalle A.D., Morgan V.A. et al. Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer. Eur. Radiol. 2016; 26 (4): 941–950. http://doi.org/10.1007/s00330-015-3899-5</mixed-citation><mixed-citation xml:lang="en">Downey K., Attygalle A.D., Morgan V.A. et al. Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer. Eur. Radiol. 2016; 26 (4): 941–950. http://doi.org/10.1007/s00330-015-3899-5</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">DeSouza N.M., Rockall A., Freeman S. Functional MR imaging in gynecologic cancer. Magn. Reson. Imaging Clin. N. Am. 2016; 24 (1): 205–222. http://doi.org/10.1016/j.mric.2015.08.008</mixed-citation><mixed-citation xml:lang="en">DeSouza N.M., Rockall A., Freeman S. Functional MR imaging in gynecologic cancer. Magn. Reson. Imaging Clin. N. Am. 2016; 24 (1): 205–222. http://doi.org/10.1016/j.mric.2015.08.008</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Woo S., Suh C.H., Kim S.Y. et al. Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: an updated systematic review and meta-analysis of the literature between 2012 and 2016. Eur. Radiol. 2018; 28 (2): 530–541. http://doi.org/10.1007/s00330-017-4958-x</mixed-citation><mixed-citation xml:lang="en">Woo S., Suh C.H., Kim S.Y. et al. Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: an updated systematic review and meta-analysis of the literature between 2012 and 2016. Eur. Radiol. 2018; 28 (2): 530–541. http://doi.org/10.1007/s00330-017-4958-x</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Park J.J., Kim C.K., Park S.Y., Park B.K. Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology. 2015; 274 (3): 734–741. http://doi.org/10.1148/radiol.14140920</mixed-citation><mixed-citation xml:lang="en">Park J.J., Kim C.K., Park S.Y., Park B.K. Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology. 2015; 274 (3): 734–741. http://doi.org/10.1148/radiol.14140920</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Sala E., Rockall A.G., Freeman S.J. et al. The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know. Radiology. 2013; 266: 717–740. http://doi.org/10.1148/radiol.12120315</mixed-citation><mixed-citation xml:lang="en">Sala E., Rockall A.G., Freeman S.J. et al. The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know. Radiology. 2013; 266: 717–740. http://doi.org/10.1148/radiol.12120315</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Raithatha A., Papadopoulou I., Stewart V. et al. Cervical cancer staging: a resident’s primer: women’s imaging. Radiographics. 2016; 36 (3): 933–934. http://doi.org/10.1148/rg.2016150173</mixed-citation><mixed-citation xml:lang="en">Raithatha A., Papadopoulou I., Stewart V. et al. Cervical cancer staging: a resident’s primer: women’s imaging. Radiographics. 2016; 36 (3): 933–934. http://doi.org/10.1148/rg.2016150173</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Eisenhauer E.A., Therasse P., Bogaerts J. et. al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009; 45 (2): 228–247. http://doi.org/10.1016/j.ejca.2008.10.026</mixed-citation><mixed-citation xml:lang="en">Eisenhauer E.A., Therasse P., Bogaerts J. et. al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009; 45 (2): 228–247. http://doi.org/10.1016/j.ejca.2008.10.026</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang A., Song J., Ma Z., Chen T. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers. Acta Radiol. 2020; 61 (6): 848–855. https://doi.org/10.1177/0284185119879686</mixed-citation><mixed-citation xml:lang="en">Zhang A., Song J., Ma Z., Chen T. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers. Acta Radiol. 2020; 61 (6): 848–855. https://doi.org/10.1177/0284185119879686</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Qi Y.F., He Y.L., Lin C.Y. et al. Diffusion-weighted imaging of cervical cancer: Feasibility of ultra-high b-value at 3T. Eur. J. Radiol. 2020; 124: 108779. http://doi.org/10.1016/j.ejrad.2019.108779</mixed-citation><mixed-citation xml:lang="en">Qi Y.F., He Y.L., Lin C.Y. et al. Diffusion-weighted imaging of cervical cancer: Feasibility of ultra-high b-value at 3T. Eur. J. Radiol. 2020; 124: 108779. http://doi.org/10.1016/j.ejrad.2019.108779</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Elsholtz F.H.J., Asbach P., Haas M. et al. Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur. Radiol. 2021; 31 (8): 6116–6124. https://doi.org/10.1007/s00330-020-07572-4</mixed-citation><mixed-citation xml:lang="en">Elsholtz F.H.J., Asbach P., Haas M. et al. Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur. Radiol. 2021; 31 (8): 6116–6124. https://doi.org/10.1007/s00330-020-07572-4</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Wong T.Z., Jones E.L., Coleman R.E. Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol. Imaging Biol. 2004; 6 (1): 55–62. http://doi.org/10.1016/j.mibio.2003.12.004</mixed-citation><mixed-citation xml:lang="en">Wong T.Z., Jones E.L., Coleman R.E. Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol. Imaging Biol. 2004; 6 (1): 55–62. http://doi.org/10.1016/j.mibio.2003.12.004</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Hameeduddin A., Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies. Cancer Imaging. 2015; 15 (1): 3. http://doi.org/10.1186/s40644-015-0037-1</mixed-citation><mixed-citation xml:lang="en">Hameeduddin A., Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies. Cancer Imaging. 2015; 15 (1): 3. http://doi.org/10.1186/s40644-015-0037-1</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Young H., Baum R., Cremerius U. et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur. J. Cancer. 1999; 35 (13): 1773–1782. http://doi.org/10.1016/s0959-8049(99)00229-4</mixed-citation><mixed-citation xml:lang="en">Young H., Baum R., Cremerius U. et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur. J. Cancer. 1999; 35 (13): 1773–1782. http://doi.org/10.1016/s0959-8049(99)00229-4</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X., Koch S. Positron emission tomography/ computed tomography potential pitfalls and artifacts. Curr. Probl. Diagn. Radiol. 2009; 38 (4): 156–169. http://doi.org/10.1067/j.cpradiol.2008.01.001</mixed-citation><mixed-citation xml:lang="en">Wang X., Koch S. Positron emission tomography/ computed tomography potential pitfalls and artifacts. Curr. Probl. Diagn. Radiol. 2009; 38 (4): 156–169. http://doi.org/10.1067/j.cpradiol.2008.01.001</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Amit A., Person O., Keidar Z. FDG PET/CT in monitoring response to treatment in gynecological malignancies. Curr. Opin. Obstet. Gynecol. 2013; 25 (1): 17–22. http://doi.org/10.1097/GCO.0b013e32835a7e96</mixed-citation><mixed-citation xml:lang="en">Amit A., Person O., Keidar Z. FDG PET/CT in monitoring response to treatment in gynecological malignancies. Curr. Opin. Obstet. Gynecol. 2013; 25 (1): 17–22. http://doi.org/10.1097/GCO.0b013e32835a7e96</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">American College of Radiology ACR Appropriateness Criteria: Pretreatment Planning of Invasive Cancer of the Cervix. https://acsearch.acr.org/docs/69461/Narrative/</mixed-citation><mixed-citation xml:lang="en">American College of Radiology ACR Appropriateness Criteria: Pretreatment Planning of Invasive Cancer of the Cervix. https://acsearch.acr.org/docs/69461/Narrative/</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Moore K.N., Herzog T.J., Lewin S. et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol. Oncol. 2007; 105 (2): 299–303. http://doi.org/10.1016/j.ygyno.2006.12.031</mixed-citation><mixed-citation xml:lang="en">Moore K.N., Herzog T.J., Lewin S. et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol. Oncol. 2007; 105 (2): 299–303. http://doi.org/10.1016/j.ygyno.2006.12.031</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Lorusso D., Petrelli F., Coinu A. et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol. Oncol. 2014; 133 (1): 117–123. http://doi.org/10.1016/j.ygyno.2014.01.042</mixed-citation><mixed-citation xml:lang="en">Lorusso D., Petrelli F., Coinu A. et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol. Oncol. 2014; 133 (1): 117–123. http://doi.org/10.1016/j.ygyno.2014.01.042</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Bodurka-Bevers D., Morris M., Eifel P.J. et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol. Oncol. 2000; 78 (2): 187–193. http://doi.org/10.1006/gyno.2000.5860.</mixed-citation><mixed-citation xml:lang="en">Bodurka-Bevers D., Morris M., Eifel P.J. et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol. Oncol. 2000; 78 (2): 187–193. http://doi.org/10.1006/gyno.2000.5860.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Scottish Intercollegiate Guidelines Network. Management of cervical cancer/ (SIGN guideline no 99) 2008; National Comprehensive Cancer Network (NCCN) guidelines for cervical cancer/ 2022</mixed-citation><mixed-citation xml:lang="en">Scottish Intercollegiate Guidelines Network. Management of cervical cancer/ (SIGN guideline no 99) 2008; National Comprehensive Cancer Network (NCCN) guidelines for cervical cancer/ 2022</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
